Brain Health Supplements and Therapeutics Market Revenue to Attain USD 47.37 Bn by 2035

Brain Health Supplements and Therapeutics Market Revenue and Trends 2026 to 2035

The global brain health supplements and therapeutics market revenue was valued at USD 18.60 billion in 2025 and is expected to attain around USD 47.37 billion by 2035, growing at a CAGR of 9.80% during forecast period. The market is driven by the increasing global occurrence of neurodegenerative disorders like Alzheimer’s disease and Parkinson’s disease, and increasing consumer demand for clinically proven supplements that help improve memory and focus.

Enhancing Mental Function Using Nootropics and Neurotherapeutics

The brain health supplements and therapeutics market includes all dietary supplements, functional foods, beverages, and drugs that promote, enhance, and improve cognitive functions, such as memory, concentration, attention, and mental clarity. It also includes medical solutions to prevent cognitive decline associated with aging and treatments for neurodegenerative diseases.

The market includes over-the-counter nootropics such as L-theanine, ginkgo biloba, omega-3 fatty acids, and adaptogens. The market also includes novel digital therapies and personalized nutrition approaches that analyze genetic and biomarker information to provide individual recommendations on brain health improvement. This market has been adopted by aging people, students, and professionals seeking enhanced performance, as well as those with cognitive issues.

Usage of Clinical Strength Plant Extracts for Cognitive Wellness

The market is moving towards clinically proven plant-based actives rather than generic vitamins. Due to modern technologies in plant-based extraction and formulation, it has become possible for companies to develop their own eco-friendly and clinically proven ingredients that can improve memory, focus, and stress resistance. Seppic unveiled SEPIBRIGHT in 2026, which is a new nootropic plant extract which is obtained by recycling strawberry leaves. A 12-week clinical study involving 98 healthy volunteers (60-80 years old) proved that the consumption of 300 mg of the active ingredient per day improves visual episodic memory by 18%, memory scores by 11% in 6 weeks, and verbal episodic memory by 25% in 12 weeks in volunteers aged 60 to 69 years.

Brain Health Brands Gain Ground Through Innovative Consumer Collaborations

The brain health supplements and therapeutics market witnesses new ways of engaging with consumers for brain health supplements brands to connect with older consumers through non-traditional means, such as clinical and retail routes. Brands are collaborating with sports teams and other fitness-related initiatives to provide accessibility to health-minded older populations. Such efforts help raise brand awareness and consumer trust with individuals who may be unaware of the existence of brain supplements. In 2026, top brain health supplement brand Prevagen announced that it would partner with the Association of Pickleball Players (APP) Tour to become the first official brain supplement partner of the APP.

Implementation of National Brain Health Programs and Funding Initiatives

Governments across the globe have rolled out their brain health programs that offer screening, diagnoses, and treatment of neurological disorders as part of their national primary healthcare strategy. The purpose of such programs is to improve accessibility to treatments for various neurological diseases by setting up special clinics, training healthcare professionals, and improving referrals. In 2025, the Indian government introduced a National Task Force for Brain Health as a precursor to launching a national brain health program based on the scale-up of the Karnataka Brain Health Initiative (KaBHI). This initiative features 32 brain clinics offering multidisciplinary treatment, rehabilitation services, tele neurology, and statewide networks of neurologists.

MOSH Gets USD 13 Million Series A Funding to Expand its Brain Health Bars

MOSH, the brain health-focused nutrition brand co-created by Maria Shriver, announced in 2026 that it had secured USD 13 million in Series A financing with a major contribution from Main Street Advisors. MOSH has reached over 2000 doors in U.S. retail stores and is set to debut in Target stores nationwide, as well as introduce MOSH High Protein bars featuring 20 g of protein, creatine, and its brain blend.

Market Segmentation Overview

• By product type, the brain health supplements segment led the brain health supplements and therapeutics market with 58% share in 2025 and is expected to expand at the highest CAGR of 10.8% during the forecast period, because of the widespread availability of these products without prescriptions, targeting a wider consumer demographic. This segment has been adopted by healthy aging individuals who seek cognitive improvement and students and professionals who seek improvement in mental focus.
• By product type, the prescription therapeutics segment held the second-largest market share of 28% in 2025, due to the fact that it caters to patients suffering from diseases like Alzheimer’s, Parkinson’s, and multiple sclerosis through the provision of disease-modifying and symptomatic treatment solutions. There have been recent approvals of disease-modifying Alzheimer’s therapies, in the form of anti-amyloid antibodies, driving the demand for prescription therapeutics. 
• By ingredient type, the omega-3 fatty acids segment dominated the market with 29% share in 2025, since it is the best-researched and best-known brain health ingredient, with several decades' worth of clinical evidence proving its positive effect on cognition, neuroprotection, and aging. It is well-recognized among consumers, approved by the FDA, and widely available in various product types.
• By ingredient type, the herbal extracts segment is expected to grow at the fastest CAGR of 11.6% from 2026 to 2035, because consumers are increasingly interested in natural and plant-derived cognitive enhancers such as bacopa monnieri, ashwagandha, lion’s mane, and ginkgo biloba, which provide safety and holistic benefits. There has been an increase in human clinical studies proving efficacy for memory, concentration, and stress resistance.
• By application, the cognitive enhancement segment led the brain health supplements and therapeutics market with 28% share in 2025 and is expected to expand at the highest CAGR of 11.5% during the forecast period, due to its wide-ranging customer base consisting of healthy individuals ranging from students to professionals to older consumers seeking to enhance their memory, concentration, and cognition. This segment has been widely adopted due to effective consumer advertising and ease of availability over-the-counter.
• By application, the memory support segment held the second-largest market share of 24% in 2025, since the most common fear of the rapidly aging global population is their deteriorating memory. Such consumers have been proven to be more loyal and ready to pay higher prices for products that can help alleviate the anxiety related to deteriorating memory.
• By distribution channel, the pharmacies and drug stores segment dominated the market with 37% share in 2025, because it is the most reliable and accessible channel for people conscious about their health, especially older ones who usually visit them for prescription medications and consult pharmacists for personalized recommendations. The presence of chain pharmacies in all neighbourhoods, their acceptance of FSA/HSA payment cards, and the impulse purchase factor for health-related goods drive the demand for this segment.
• By distribution channel, the online retail segment is expected to grow at the fastest CAGR of 13.5% from 2026 to 2035, due to the fact that it provides a high level of convenience, the availability of a broad range of products, and the ability to compare prices and review products. This segment facilitates consumers getting detailed technical information about different types of medications while sitting comfortably at home.
• By end user, the adult (18-64 years) segment led the market with 52% share in 2025, since it includes the biggest, most economically active age group with the highest disposable income and has a significant inclination towards investing in the prevention of diseases, cognitive enhancement, and mental performance improvement.
• By end user, the geriatric population (65+ years) segment is expected to expand at the highest CAGR of 11% during the forecast period, because world demographics are changing at an unparalleled rate, with the number of people aged 65 and above estimated to double by 2050, and this group has the highest chance of experiencing cognitive impairment, dementia, and Alzheimer’s disease. The advent of disease-modifying Alzheimer’s disease drugs has led to the emergence of a huge and fast-growing patient base that needs diagnosis and medication.

Regional Analysis

North America led the brain health supplements and therapeutics market with 39% share in 2025, due to a very high number of health-conscious individuals who are also financially well-off, a well-developed healthcare system, and early adoption of wellness and preventive care products. The U.S. dominated the market in North America because of the existence of a large dietary supplements industry, high consumer expenditure in cognitive health products, and effective direct-to-consumer marketing strategies. Canada witnessed notable market growth owing to the significant presence of health-conscious consumers, a favorable environment for natural health products, and the rising consumer demand for cognitive support supplements in its aging population.

Asia-Pacific is expected to grow at the fastest CAGR of 12.4% from 2026 to 2035, because it has the largest and rapidly aging population in the world, which causes high incidences of dementia and cognitive impairment, which drives the demand for both over-the-counter and prescription drugs. China led the market in Asia-Pacific due to its large elderly population, growing disposable income, significant investments by the government in brain health campaigns, and a rapidly growing supplements and drug industry. India is a significant contributor to the market owing to its growing population of elderly people, growing awareness about brain health issues, and the rise of the nutraceutical industry, which is quickly adapting to worldwide developments in cognitive health.

Europe held the second-largest market share of 27% in 2025, because of the high prevalence of dementia and cognitive deterioration, an excellent healthcare system supporting early diagnosis and cognitive testing, and heavy investments in brain health research and digital health innovations. Germany dominated the market in Europe due to its well-developed pharmaceutical and nutraceutical industries, high levels of consumer awareness regarding cognitive health, and quick adoption of digital health applications. The UK witnessed notable market growth owing to its significant emphasis on early diagnosis of dementia, widespread use of digital cognitive tests by primary care doctors, and a growing supplement market targeting aged people.

Brain Health Supplements and Therapeutics Market Coverage

Top Companies in the Brain Health Supplements and Therapeutics Market

Biogen, Eisai, Roche, and Lundbeck are some of the key players that specialize in developing disease-modifying drugs for Alzheimer’s and other neurodegenerative diseases. Abbott, Nestle Health Science, and Danone manufacture medical nutrition and brain health supplements. Otsuka Pharmaceutical provides both prescription and nutraceuticals for brain health and wellness. Amway, Herbalife, NOW Foods, Nature’s Bounty, and Thorne HealthTech are some of the leading brands of nutraceuticals and dietary supplements.

Segments Covered in This Report

By Product Type

• Brain Health Supplements
• Prescription Therapeutics
• Medical Nutrition Products

By Ingredient Type

• Omega-3 Fatty Acids
• Herbal Extracts
• Vitamins and Minerals
• Amino Acids and Proteins
• Others

By Application

• Cognitive Enhancement
• Memory Support
• Alzheimer's Disease and Dementia
• Mental Wellness and Stress Management
• ADHD and Attention Support
• Others

By Distribution Channel

• Pharmacies and Drug Stores
• Online Retail
• Specialty Nutrition Stores
• Hospitals and Clinics

By End User

• Adults (18–64 Years)
• Geriatric Population (65+ Years)
• Pediatric Population

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/8520

You can place an order or ask any questions. Please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344